Sign inJoin waitlistJoin the waitlist

FW

Frank Waldron-Lynch

Credentials:

History

Residency
2008–2011
Medical School
2004–2008

Research

Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial
Diabetologia · 2013 · 139 citations
Teplizumab induces human gut-tropic regulatory cells in humanized mice and patients
Science Translational Medicine · 2012 · First of 7 authors · 78 citations
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes
Review · Nature Reviews Drug Discovery · 2011 · First of 2 authors · Corresponding · 62 citations

Kevan Herold
10 papers
DC
Daniel Clegg
2 papers
James Tooley
2 papers
Aaron Michels
1 paper
AH
Alexis Hakim
1 paper
AC
Ann Chauffe
1 paper
Bela Patel
1 paper
Gerard Criner
1 paper
Hollis O'Neal
1 paper
Jane Buckner
1 paper
JS
Jennifer Sherr
1 paper · 1 as a fellow
JM
Jesse Matthews
1 paper